Overview
Camille Laberthonniere practices in Marseille, France. Ms. Laberthonniere is rated as an Advanced expert by MediFind in the treatment of Microphthalmia. Her top areas of expertise are Bosma Arhinia Microphthalmia Syndrome, Microphthalmia, Choanal Atresia, and Facioscapulohumeral Muscular Dystrophy (FSHD).
Her clinical research consists of co-authoring 12 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Microphthalmia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Bosma Arhinia Microphthalmia SyndromeMs. Laberthonniere isAdvanced. Learn about Bosma Arhinia Microphthalmia Syndrome.
- Choanal AtresiaMs. Laberthonniere isAdvanced. Learn about Choanal Atresia.
- Facioscapulohumeral Muscular Dystrophy (FSHD)Ms. Laberthonniere isAdvanced. Learn about Facioscapulohumeral Muscular Dystrophy (FSHD).
- MicrophthalmiaMs. Laberthonniere isAdvanced. Learn about Microphthalmia.
- Experienced
- Glycogen Storage Disease Type 5Ms. Laberthonniere isExperienced. Learn about Glycogen Storage Disease Type 5.
- HypogonadismMs. Laberthonniere isExperienced. Learn about Hypogonadism.
- PanhypopituitarismMs. Laberthonniere isExperienced. Learn about Panhypopituitarism.
- Septo-Optic DysplasiaMs. Laberthonniere isExperienced. Learn about Septo-Optic Dysplasia.